A study published Jan. 11, 2023, in the Journal of Dental Research (JDR) compared the effectiveness of 10 pharmacological interventions in developing guidelines for the management of acute pain after tooth extraction in adults.
North America is in the midst of an opioid crisis, which is a major public health and safety concern. In dentistry, many patients are prescribed opioids for the first time to manage acute postoperative pain after dental impaction surgery, often resulting in the prescription of an excessive amount of opioid pills, increasing the risk of misuse, abuse and addiction. Of more than half a million patient dental visits between 2011 and 2015, 29% of prescribed opioids exceeded the morphine equivalent recommended for the appropriate treatment of acute pain and more than half exceeded recommended supply days.
The study, led by Anna Miroshnychenko of McMaster University's School of Health Sciences and colleagues, involved a systematic review and a network meta-analysis to assess the comparative effectiveness of 10different pharmacological interventions for pain management following simple and surgical tooth extraction. and pain associated with pulpitis or its complications.
The systematic review was conducted to inform the 2022 evidence-based clinical practice guidelines produced by the American Dental Association (ADA) Council on Scientific Affairs, the ADA Research and Science Institute and the University of Pittsburgh and University of Pennsylvania schools of dentistry medicine in collaboration with the U.S. Food and Drug Administration for the treatment of acute dental pain.
The researchers concluded that, based on moderate- and high-certainty evidence, in individuals undergoing surgical tooth extractions, the interventions ranked as the most effective for pain relief were ibuprofen 200-400 mg plus acetaminophen 500-1,000 mg, acetaminophen 650 mg plus oxycodone 10 mg, ibuprofen 400 mg, and naproxen 400-440 mg.
In addition, NSAIDs with or without acetaminophen produce better pain-related outcomes than opioids with or without acetaminophen (except acetaminophen 650 mg plus oxycodone 10 mg) or placebo. Future research should focus on the evaluation of 200 mg ibuprofen plus 5 mg hydrocodone, 5 mg hydrocodone plus 300-325 mg acetaminophen and 37.5 mg tramadol plus 325 mg acetaminophen through randomized clinical trials.
This article originally appeared on Odontologia33.
A. Miroshnychenko et al. "Acute Postoperative Pain Due to Dental Extraction in the Adult Population: A Systematic Review and Network Meta-analysis." Journal of Dental Research. (2023). DOI: 10.1177/00220345221139230
Restorative dentistry 07 June 2024
This scoping review and analysis were designed to assess the amount of time spent delivering photobiomodulation light therapy after dental extraction to improve postoperative pain and wound healing.
Orthodontics 05 April 2023
Post-treatment stability after five years of retention with vacuum-formed and bonded retainers
The aim of this randomized controlled trial is to evaluate and compare post-treatment changes in the maxilla and mandible after five years of retention with two different retention protocols. The...
Endodontics 08 March 2023
This study analyzes the impact of the chosen platelet-rich fibrin preparation protocol on wound healing and alveolar ridge preservation.
Market 10 January 2023
Oral and maxillofacial surgeons: provider of choice for wisdom teeth removal, dental implants
The findings stem from annual national consumer surveys conducted from 2017 to 2022 commissioned by the American Association of Oral and Maxillofacial Surgeons.
Editorials 10 October 2025
With proud smiles and crisp white coats, ninety-three learners from the DDS Class of 2029 and the International Dentist Pathway Class of 2028 marked the start of their dental careers at the UCSF...
Periodontology 10 October 2025
Continuous professional development (CPD) in Periodontology refers to the overall framework of opportunities that facilitate a life-long learning practice, driven by the learner-practitioner and...
TheraBreath, the #1 alcohol-free mouthwash brand in the U.S.*, has introduced a new line of dentist-formulated, clinically tested toothpastes designed to support professional oral care...
News 10 October 2025
New officers and trustees were installed at the Minnesota Dental Association’s Leadership Conference on September 19 in Minneapolis.
News 10 October 2025
Smartee Denti-Technology today announced that Professor Gang Shen, its Chief Scientist and Executive President of TaiKang ByBo Dental, has once again been named to the World’s Top 2% Scientists...